http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SG-11201806771R-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52c68e4149a6c462b850d4e7cc2b2f9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J31-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-36 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J31-00 |
| filingDate | 2017-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1c1f998433eddfa4452cae6a4755c48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c704dd72318418d7899172649756b6d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6cb7e73753d29287f67de89ccd1be59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faf81780449a134cb08ae03930c93624 |
| publicationDate | 2018-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SG-11201806771R-A |
| titleOfInvention | Prodrugs of the selective progesterone receptor modulator (sprm) (11.beta.,17.beta.)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroeth yl)estra-4,9-dien-3-one |
| abstract | OHC F5 H HO 0 `er 0 W O 20 17 / 148977 Al (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/148977 Al 8 September 2017 (08.09.2017) WIPO I PCT 1111111111111101110111111111110101111101110101111111011110111111111111111111110111111 (51) International Patent Classification: C07J 31/00 (2006.01) A61P 5/36 (2006.01) A61K 31/567 (2006.01) (21) International Application Number: PCT/EP2017/054704 (22) International Filing Date: 1 March 2017 (01.03.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 16158598.9 4 March 2016 (04.03.2016) EP (71) Applicant: BAYER PHARMA AKTIENGESELL- SCHAFT [DE/DE]; Miillerstr. 178, 13358 Berlin (DE). (72) Inventors: MILITZER, Hans-Christian; Waldweg 2, 51519 Odenthal (DE). ROTTMANN, Antje; Schneehorn- pfad 11A, 13089 Berlin (DE). WAGENFELD, Andrea; Weddingenweg 64, 12205 Berlin (DE). IRLBACHER, Horst; Winsstrasse 47, 10405 Berlin (DE). (74) Agent: BIP PATENTS; Alfred-Nobel-Str. 10, NRW, 40789 Monheim am Rhein (DE). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.1700) Published: — with international search report (Art. 21(3)) (54) Title: PRODRUGS OF THE SELECTIVE PROGESTERONE RECEPTOR MODULATOR (SPRM) (11.BETA.,17.BETA.)- 17-HYDROXY-11-[4-(METHYLSULPHONYL)PHENYL]-17-(PENTAFLUOROETH YL)ESTRA-4,9-DIEN-3-ONE (57) : This invention concerns Selective Progesterone Receptor Modulators (SPRM) in a prodrug form as well as their ap- plication in therapy. (3a, 11(3,1713)-1 144-(methylsulfonyl)pheny1]-17-(pentafluoroethypestra-4,9-diene-3,17-diol (Compound 1) is one of the invention prodrugs. |
| priorityDate | 2016-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811 |
Total number of triples: 21.